Staphylococcal Infections
📧 Sign up to get email alerts when something new happens for Staphylococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-05-28Clinical Trial Update: A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis [Phase 1, Phase 2]
The trial evaluating tolerability and early efficacy of the hLF1-11 peptide in bacteremia due to Staphylococcus epidermidis has been withdra…
-
EMA withdrawal · 2008-10-24EMA Application withdrawn: Vibativ (telavancin) — Astellas Pharma Europe B. V.
EMA withdrew the application for Vibativ (telavancin) by Astellas Pharma Europe B. V.; therapeutic areas include skin infections and staphyl…
-
EMA withdrawal · 2008-09-10EMA Application withdrawn: Exulett — Pfizer Limited
EMA reports withdrawal of the Exulett application by Pfizer Limited for skin and soft tissue infections and staphylococcal infections.